Abstract
Objective
To evaluate the renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines.
Design
Prospective, clinical study using sequential periods.
Setting
A 12-bed surgical intensive care unit in a university hospital.
Patients
14 patients with sepsis syndrome and 15 patients with septic shock treated with exogenous catecholamines were studied. They had no diuretic treatment.
Intervention
Two periods of 2 h each with and without 2μg·kg−1·min−1 of dopamine infusion. Hemodynamic and renal data were obtained at the end of each period. Measurements were repeated after 48 h of dopamine infusion in patients with sepsis syndrome. All data were evaluated by the Wilcoxon rank test.
Measurements and results
In patients with sepsis syndrome, diuresis and creatinine clearance increased significantly by 100% and 60%, respectively, during low-dose dopamine infusion without any change in systemic hemodynamics. The renal response to dopamine decreased significantly after 48 h of dopamine infusion (P<0.01). In patients with septic shock treated with catecholamines, no variation of either systemic hemodynamics or renal function was noted during low-dose dopamine infusion.
Conclusion
The renal effects of low-dose dopamine in patients with sepsis syndrome decrease with time. No renal effect of low-dose dopamine was observed in patients with septic shock treated with catecholamines. These findings suggest a desensitization of renal dopaminergic receptors.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hebert PC, Drummond AJ, Singezr J, Bernard GR, Russell JA (1993) A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 104: 230–235
Lowell JA, Schifferdecker C, Driscoll DF, Benotti PN, Bistrian BR (1990) Postoperative fluid overload: not a benign problem. Crit Care Med 18: 728–733
Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) Prognosis in acute organ system failure. Ann Surg 202: 685–693
Regnier B, Rapin M, Gory G, Lemaire F, Teisseire B, Harari A (1977) Haemodynamic effects of dopamine in septic shock. Intensive Care Med 3: 47–53
Duke GJ, Bersten AD (1992) Dopamine and renal salvage in the critically ill patient. Anaesth Intensive Care 20: 277–302
Goldberg LI, McDonald RH, Zimmerman AM (1983) Sodium diuresis produced by dopamine in patients with congestive heart failure. N Engl J Med 14: 1060–164
McDonald RH, Goldberg LI, McNay JL, Tuttle EP (1964) Effects of dopamine in man: augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. J Clin Invest 43: 1116–1124
D'Orio V, El Allaf D, Juchmes J, Marcelle R (1984) The use of low doses of dopamine in intensive care medicine. Arch Int Physiol Biochim 2: 511–520
Parker S, Carlon G, Isaacs M, Howland WS, Kahn RC (1981) Dopamine administration in oliguria and oliguric renal failure. Crit Care Med 9: 630–632
Szerlip HM (1991) Renal dose dopmine:fact and fiction. Ann Intern Med 115: 153–154
Schaer GL, Fink MP, Parillo JE (1985) Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med 13: 492–496
Fink MP, Nelson R, Roethel R (1985) Low-dose dopamine preserves renal blood flow in endotoxin shocked dogs treated with ibuprofeh. J Surg Res 38: 582–591
Orme ML, Breckenridge A, Dollery CT (1973) The effects of long term administration of dopamine on renal function in hypertensive patients. Eur J Clin Pharmacol 6: 150–155
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Comittee. Chest 101: 1644–1655
Lindner A (1983) Synergism of dopamine and furosemide in diuretic-resistant oliguric acute renal failure. Nephron 33: 121–126
Le Gall JR and the French multicenter group of ICU research (1989) Factors related to outcome in intensive care: French multicenter study. Crit Care Med 17: 305–308
Elebute EA, Stoner HB (1983) The grading of sepsis. Br J Surg 70: 29–32
Le Corre P, Malledant Y, Tanguy M, Le Verge R (1993) Steady state pharmacokinetics of dopamine in adult patients. Crit Care Med 21: 1652–1657
Wilson RF, Soullier G (1980) The validity of two-hour creatinine clearance studies in critically ill patients. Crit Care Med 8: 281–283
Sladen RN, Endo E, Harrison T (1987) Two-hour versus 22 h creatinine clearance in critically ill patients. Anesthesiology 67: 1013–1016
Schwartz D, Lazar P, Papoz L (1985) Statistiques médicales et biologiques. In: Schwartz D (ed) Flammarion pp 95 117, pp 277–284
Martin C, Eon B, Saux P, Aknin P, Gouin F (1990) Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 18: 282–285
Martin C, Papazian L, Perrin G, Saux P, Gouin F (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 103: 1826–1831
Flancbaum L, Choban PS, Dasta JF (1994) Quatitative effects of low dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med 22: 61–66
Tamaki T, Hura CE, Kunau RT (1989) Dopamine stimulates cAMP production in canine afferent arterioles via DA1 receptors. Am J Physiol 256: 626–629
Seri I, Kone BC, Gullans SR et al. (1988) Locally formed dopamine inhibits Na+-K+-ATPase activity in rat cartical tubule cells. Am J Physiol 255: F666–673
Felder RA, Blecher M, Calcagno PL, et al (1984) Dopamine receptors in the proximal tubule of the rabbit. Am J Physiol 247: 499–505
Waelbroek M, Taton G, Delhaye M, Chatelain P, Camus JC, Pochet R, Leclerc JL, Desmet JM, Robberecht P, Christophe J (1983) The human heart beta-adrenergic receptors: coupling of beta 2-adrenergic receptors with the adenylate cyclase system. Mol Pharmacol 24: 174–182
Bristow MR, Ginsburg R, Minobe W, Cubiccioti RS, Scott Sageman W, Keith Lurie MS, Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and betaadrenergic receptor density in failing human hearts. N Engl J Med 307: 205–211
Tashkin DP, Conolly ME, Deutsch RI, Hui KK, Littner M, Scarpace P, Abrass I (1982) Subsensitization of betaadrenoceptors in airways and lymphocytes of healthy and asthmatic subjects. Am Rev Respir Dis 125: 185–193
Bristow MR, Laser JA, Minobe W, Ginsburg R, Fowler MB, Rasmussen R (1984) Selective down-regulation of beta 1 adrenergic receptors in the failing human heart. Circulation 70: 61–67
Strigle TR, Petrinec D (1990) The effect of renal range dopamine and norepinephrine infusions on the renal vasculature. Am Surg 56: 494–496
Sibley DR, Lefkowitz RJ (1985) Molecular mechanism of receptor desensitization using beta adrenergic receptor coupled adenylate cyclase system as a model. Nature 317: 124–129
Schwinn DA (1993) Adrenoceptors as model for G protein-coupled receptors: structure, function and regulation. Br J Anaesth 71: 77–85
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lherm, T., Troché, G., Rossignol, M. et al. Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med 22, 213–219 (1996). https://doi.org/10.1007/BF01712239
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01712239